Z. G. Surmell Et Al. , "Docetaxel/doxorubicin/cyclophosphamide (TAC) chemotherapy for operable HER2-negative, node-positive breast cancer patients: Results from a single institution.," JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.15, 2010
Surmell, Z. G. Et Al. 2010. Docetaxel/doxorubicin/cyclophosphamide (TAC) chemotherapy for operable HER2-negative, node-positive breast cancer patients: Results from a single institution.. JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.15 .
Surmell, Z. G., Aksoy, S., Dizdar, O., Dede, D. S., Dogan, E., Arslan, C., ... Gullu, I. H.(2010). Docetaxel/doxorubicin/cyclophosphamide (TAC) chemotherapy for operable HER2-negative, node-positive breast cancer patients: Results from a single institution.. JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.15.
Surmell, Z. Et Al. "Docetaxel/doxorubicin/cyclophosphamide (TAC) chemotherapy for operable HER2-negative, node-positive breast cancer patients: Results from a single institution.," JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.15, 2010
Surmell, Z. G. Et Al. "Docetaxel/doxorubicin/cyclophosphamide (TAC) chemotherapy for operable HER2-negative, node-positive breast cancer patients: Results from a single institution.." JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.15, 2010
Surmell, Z. G. Et Al. (2010) . "Docetaxel/doxorubicin/cyclophosphamide (TAC) chemotherapy for operable HER2-negative, node-positive breast cancer patients: Results from a single institution.." JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.15.
@article{article, author={Z. G. Surmell Et Al. }, title={Docetaxel/doxorubicin/cyclophosphamide (TAC) chemotherapy for operable HER2-negative, node-positive breast cancer patients: Results from a single institution.}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2010}